Pat Noland Joined Boston Heart in April 2017 as President.

Pat brings a wealth of leadership experience in laboratory sciences. He has proven success in developing and executing strategies for revenue and earnings growth as well as leadership, communication, people and organizational development. For the past 25 years, Pat has worked for various companies such as Laboratory Corporation of America (LabCorp), StrataDx- Strata Pathology Services Inc., and Genetic Signatures Limited.

“With Pat’s vast experience in Laboratory Sciences, he is the perfect fit for the organization,” said Bob Gorman, Senior Vice President, Clinical Diagnostics, US-East Eurofins.

Pat has most recently been working as a US Market Consultant at Genetic Signatures Limited since July 2016— previously serving as Executive Vice President of US Operations.

Prior to his time at Genetic Signatures Limited, he served as Chief Executive Officer of Strata Pathology Services, Inc. where he repositioned the company to focus on institutional and dermatology markets.

He had a 17-year tenure at the $9.7 billion clinical laboratory company, LabCorp, where he served as Senior Vice President, responsible for developing and implementing a new partnerships-focused hospital strategy, designed to expand the available US market. Hospital services contributed approximately $480 million to company revenues in 2010. Previously, he held full P&L responsibility for DIANON Systems, LabCorp’s premium anatomic pathology brand, as well as a series of other senior leadership roles in strategic assignments. Pat began his LabCorp career in field sales and sales management in the Atlanta, Georgia market.

He holds a master’s degree in Business Administration from Kennasaw State University in Georgia, and a bachelor’s of science degree in Advertising from the University of Georgia in Athens.